Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Psychiatry: Anti-inflammatory Medication in Immuno-metabolic Depression

NCT05415397 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT05415397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05415397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Psychiatry: Anti-inflammatory Medication in Immuno-metabolic Depression
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Phase 3
Overall status
Completed
Start date
September 28, 2022
Completion date
June 19, 2026
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major, inflammation